AE | adverse event |
AHCC®® | active hexose correlated compound |
FFLZ | fucose-containing fraction of G. lucidum |
HCC | hepatocellular carcinoma |
HP | hematologic parameters |
IC50 | half-maximal inhibitory concentration |
LOA | loss of appetite |
MDS | myelodys plastic syndromes |
MM | medicinal mushrooms |
OS | overall survival |
QOL | quality of life |
RCT | randomized, placebo-controlled, double-blind clinical trial |
ROS | reactive oxygen species |
SDL | superfine dispersed lentinan |
SPG | polysaccharide schizophyllan |